These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2465197)

  • 1. Mechanism of defective insulin-receptor kinase activity in NIDDM. Evidence for two receptor populations.
    Brillon DJ; Freidenberg GR; Henry RR; Olefsky JM
    Diabetes; 1989 Mar; 38(3):397-403. PubMed ID: 2465197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
    Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
    Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
    Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
    J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.
    Freidenberg GR; Henry RR; Klein HH; Reichart DR; Olefsky JM
    J Clin Invest; 1987 Jan; 79(1):240-50. PubMed ID: 3540010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
    Sinha MK; Pories WJ; Flickinger EG; Meelheim D; Caro JF
    Diabetes; 1987 May; 36(5):620-5. PubMed ID: 3032715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM.
    Maegawa H; Shigeta Y; Egawa K; Kobayashi M
    Diabetes; 1991 Jul; 40(7):815-9. PubMed ID: 1647993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin receptor tyrosine kinase activity and internalization in monocytes of non-insulin-dependent diabetes mellitus patients.
    Trischitta V; Giorgino F; Frittitta L; Scalisi R; Vigneri R
    Metabolism; 1993 Jul; 42(7):882-7. PubMed ID: 8393956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR
    Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatropic diabetes.
    Magré J; Grigorescu F; Reynet C; Caron M; Capony JP; White MF; Picard J; Mirouze J; Capeau J
    J Clin Endocrinol Metab; 1989 Jul; 69(1):142-50. PubMed ID: 2543688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation.
    Baron V; Gautier N; Rochet N; Ballotti R; Rossi B; Saint-Pierre S; Van Obberghen E; Dolais-Kitabgi J
    Biochem J; 1989 Jun; 260(3):749-56. PubMed ID: 2764902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of tyrosine phosphorylation of insulin receptors during the initial response of intact cells to insulin.
    Pang DT; Sharma BR; Shafer JA; White MF; Kahn CR
    J Biol Chem; 1985 Jun; 260(11):7131-6. PubMed ID: 2581963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.
    Freidenberg GR; Reichart D; Olefsky JM; Henry RR
    J Clin Invest; 1988 Oct; 82(4):1398-406. PubMed ID: 3170749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis of serine and tyrosine autophosphorylation by the human insulin receptor.
    Baltensperger K; Lewis RE; Woon CW; Vissavajjhala P; Ross AH; Czech MP
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7885-9. PubMed ID: 1381504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered.
    Kellerer M; Coghlan M; Capp E; Mühlhöfer A; Kroder G; Mosthaf L; Galante P; Siddle K; Häring HU
    J Clin Invest; 1995 Jul; 96(1):6-11. PubMed ID: 7615833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor dephosphorylation in permeabilized adipocytes is inhibitable by manganese and independent of receptor kinase activity.
    Mooney RA; Green DA
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1200-6. PubMed ID: 2475105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the insulin receptor (B-10) can stimulate tyrosine phosphorylation of the beta-subunit of the insulin receptor and a 185,000 molecular weight protein in rat hepatoma cells.
    Takayama-Hasumi S; Tobe K; Momomura K; Koshio O; Tashiro-Hashimoto Y; Akanuma Y; Hirata Y; Takaku F; Kasuga M
    J Clin Endocrinol Metab; 1989 Apr; 68(4):787-95. PubMed ID: 2466044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in beta-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase.
    Burgess JW; Wada I; Ling N; Khan MN; Bergeron JJ; Posner BI
    J Biol Chem; 1992 May; 267(14):10077-86. PubMed ID: 1374397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophosphorylation and kinase activity of insulin receptor in diabetic rats.
    Okamoto M; White MF; Maron R; Kahn CR
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E542-50. PubMed ID: 2430467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus.
    Obermaier-Kusser B; White MF; Pongratz DE; Su Z; Ermel B; Muhlbacher C; Haring HU
    J Biol Chem; 1989 Jun; 264(16):9497-504. PubMed ID: 2722845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW; Jansson PA; Posner BI; Smith U; Eriksson JW
    Diabetologia; 1997 Oct; 40(10):1197-203. PubMed ID: 9349602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.